1. Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. Key Insights 1. Pipeline Analysis of Key Global Players 2. Pricing Analysis Of Key Products 3. Key Mergers and Acquisitions 4. Prevalence of Pneumonia in Germany 5. Immunization Coverage of Pediatric Patients in Germany 5. Germany Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2016-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Product Type 1. PCV10 2. PCV13 3. PPSV23 3. Market Analysis, Insights and Forecast – By End User 1. Hospitals 2. Clinics 3. Others 4. Market Analysis, Insights and Forecast – By Geography 1. Baden-Württemberg 2. Bayern 3. Nordrhein-Westfalen 4. Hessen 5. Niedersachsen 6. Sachsen 7. Berlin 8. Others 6. Competitive Analysis 1. Germany Market Share Analysis (2018) 2. Comparative Analysis – Major Players 3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 1. Pfizer 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 2. Merck & Co. Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 3. GlaxoSmithKline plc 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 4. Sanofi 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) LIST OF FIGURES: Figure 1: Germany Pneumococcal Vaccines Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026 Figure 2: Germany Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 & 2026 Figure 3: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by PCV10, 2015-2026 Figure 4: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by PCV13, 2015-2026 Figure 5: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by PPSV23, 2015-2026 Figure 6: Germany Pneumococcal Vaccines Market Value Share (%), by End User, 2018 & 2026 Figure 7: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Hospitals, 2015-2026 Figure 8: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Clinics, 2015-2026 Figure 9: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Others, 2015-2026 Figure 10: Germany Pneumococcal Vaccines Market Value (US$ Mn), by Region, 2018 & 2026 Figure 11: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Baden-Württemberg, 2015-2026 Figure 12: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Bayern, 2015-2027 Figure 13: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Nordrhein-Westfalen, 2015-2028 Figure 14: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Hessen, 2015-2029 Figure 15: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Niedersachsen, 2015-2030 Figure 16: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Sachsen, 2015-2031 Figure 17: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Berlin, 2015-2032 Figure 18: Germany Pneumococcal Vaccines Market Forecast (US$ Mn), by Others, 2015-2033

Pfizer Merck & Co. Inc. GlaxoSmithKline plc Sanofi